Glenmark slashes covid-19 drug FabiFlu price by 27% to ₹75 a pill1 min read . Updated: 14 Jul 2020, 06:41 AM IST
With this price reduction, the company was passing on the benefits it got from higher yields and better scale, as both the API and formulations are made at Glenmark’s facilities in India
NEW DELHI : Glenmark Pharmaceuticals Ltd announced on Monday that it has reduced the price of its covid-19 drug FabiFlu by 27% to ₹75 per pill. The branded generic of favipiravir was earlier sold at ₹103 per pill.
Select your Category